Veterinary/animal vaccines are injected to animals to improve health conditions, increase production of livestock in economical way and prevent transmission of infectious diseases. These vaccines provide immunity against bacterial, viral, protozoal, and multicellular pathogens. Consequently, it prevents death of animals, loss of milk & meat, and economic losses of owners. It also helps in prevention of animal to human transmission of infectious diseases.
Increase in livestock and instances of disease and incidence of zoonotic diseases drive growth of the world veterinary/animal vaccines market. In addition, emergence of new types of vaccines supplements the growth. Rising maintenance costs for storage of vaccines and increasing prices of meat are hindering the growth of the market. Technological advancements such as DNA vaccines and awareness of animal health in emerging economies would present tremendous opportunities.
The world veterinary/animal vaccines market is segmented based on product, diseases, technology, and regions. The product segment is further classified into livestock, companion, poultry, equine, and porcine. On the basis of diseases, the market is further categorized into rabies, distemper, foot and mouth, gumboro, swine and avian influenza, and strangles. Technologies covered in the report include live attenuated, DNA, and inactivated. The market is divided based on geography into North America, Europe, Asia, and Latin America, Middle East and Africa (LAMEA).
The prominent manufacturers operating in the market are Bayer Healthcare, Bioniche Animal Health, Boehringer Ingelheim, Ceva Animal Health, Elanco Animal Health, Heska Corporation, Merck Animal Healthcare, Zoetis, Merial Inc., and Virbac. Agreements, approvals, mergers & acquisitions, partnerships, joint ventures, collaborations, expansions, and others are some of the key strategies adopted by these companies to strengthen their position in the market.
KEY BENEFITS FOR STAKEHOLDERS:
KEY MARKET SEGMENTS:
KEY MARKET PLAYERS:
SIMILAR MARKET STUDIES
The Global Vision Screener Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Vision Screener industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the ...
April 2017 | $2800 | View Details >>
This report studies sales (consumption) of Active Pharmaceutical Ingredient in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering Aurobindo Pharma Novartis International Teva Pharmaceutical ...
July 2016 | $4000 | View Details >>
Notes: Sales, means the sales volume of a-bisabolol Revenue, means the sales value of a-bisabolol This report studies sales (consumption) of a-bisabolol in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in ...
February 2011 | $118 | View Details >>
Notes: Sales, means the sales volume of Cloud Computing in Pharmaceutical Revenue, means the sales value of Cloud Computing in Pharmaceutical This report studies sales (consumption) of Cloud Computing in Pharmaceutical in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, ...
December 2016 | $3900 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research